The Legal 500: Pharmaceutical Advertising Country Comparative Guide
Written By
Partner
France
I'm a partner in our international Commercial group, based in Paris, where I provide our clients with strategic commercial advice.
Partner
Germany
As a partner in our Munich team, I advise clients in the life sciences and healthcare sectors on matters at the intersection of IP, unfair competition, and regulatory law. I am a member of our Intellectual Property Practice Group as well as our Life Sciences and Healthcare Sector Group.
Partner
UK
As one of our firm's most experienced intellectual property partners, specialising in transactional IP matters, I offer a wealth of knowledge to businesses at the cutting edge of research, development and technology, in a variety of sectors for which IP is of prime importance.
Related
Practices
Sectors
Regions
Countries
The Legal 500: Pharmaceutical Advertising Guide 2021 is a practical cross-border insight into pharmaceutical advertising, with contributing editor Sally Shorthose.
Each chapter of this guide provides information about the current issues affecting pharmaceutical advertising in a particular country and addresses topics such as self-regulation, press releases, gifts, samples, grants or donations, anti-bribery rules, regulatory authorities and courts, as well as insight and opinion on the most common issues in their respective country.
Read our overview of Pharmaceutical Advertising laws and regulations applicable in:
Australia
France
Read our chapter here >
Germany
Read our chapter here >
UK
